Skip to main content
. 2022 Jan 17;16(3):64. doi: 10.3892/mco.2022.2497

Table II.

Baseline cfDNA levels and tumor response according to RECIST version 1.1.

Best response Total (n=45)a <75th percentile (n=33) ≥75th percentile (n=12)
DC (PR+SD) 35(78) 30(91) 5 (42%)
PD 10(22) 3(9) 7 (58%)

P=0.001 according to Fisher's exact test. The total cohort (n=47) was dichotomized acccording to the 75th percentile of cfDNA levels at baseline.

aFor two patients, the first response evaluation had not yet been performed. cfDNA, cell-free DNA; DC, disease control; PR, partial response; SD, stable disease; PD, progressive disease.